Afrezza

2 Biotech Approval Outcomes That Might Affect You

2 Biotech Approval Outcomes That Might Affect You

Motley Fool

Can Mannkind Deliver A Summer Blockbuster?

Can Mannkind Deliver A Summer Blockbuster?

Seeking Alpha

MannKind: It All Comes Down To This

MannKind: It All Comes Down To This

Seeking Alpha

MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes

MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes

Yahoo

The Run-Up Trade: Biodel's Insulin Trial Results

The Run-Up Trade: Biodel's Insulin Trial Results

TheStreet.com

MannKind's Afrezza And The Oramed Threat

MannKind's Afrezza And The Oramed Threat

Seeking Alpha

MannKind's Countdown to Liftoff?

MannKind's Countdown to Liftoff?

Motley Fool

3 Drug Catalysts to Watch in 2013

3 Drug Catalysts to Watch in 2013

Motley Fool

MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It

MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It

TheStreet.com